Surgery Partners, Inc. Announces Increased Consent Fee in Consent Solicitation
Surgery Partners, Inc. has amended its ongoing consent solicitation for its subsidiary's 7.250% Senior Notes due 2032 to increase the consent fee offered to holders.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Surgery Partners, Inc. has amended its ongoing consent solicitation for its subsidiary's 7.250% Senior Notes due 2032 to increase the consent fee offered to holders.
Filed: 2026-11-18 AccNo: 0001104659-26-129346 Size: 246 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Surgery Partners, Inc. has initiated a consent solicitation for its subsidiary's $1.225 billion in outstanding 7.250% Senior Notes due 2032.
Mizuho Securities has downgraded Surgery Partners from Outperform to Neutral, setting a price target of $25.
RBC Capital Markets has increased its price target for Surgery Partners, Inc. while maintaining a Sector Perform rating.